Use of influenza antivirals during 2003-2004 and monitoring of neuraminidase inhibitor resistance.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Releve epidemiologique hebdomadaire

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15918290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

  2016cites this paper
• Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses

  2014cites this paper
• Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal

  2013cites this paper
• Influenza: The 2009 H1N1 Pandemic And Antiviral Treatment Options

  2010cites this paper
• Developing new antiviral agents for influenza treatment: what does the future hold?

  2009cites this paper
• Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007

  2009cites this paper
• Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

  2009cites this paper
• Influenza virus resistance to oseltamivir: what are the implications?

  2009cites this paper
• Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.

  2009cites this paper
• Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

  2009cites this paper
• Rapid Quantitation of Neuraminidase Inhibitor Drug Resistance in Influenza virus Quasispecies

  2008cites this paper
• Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.

  2008cites this paper
• Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects

  2007cites this paper
• John F. Enders lecture 2006: antivirals for influenza.

  2007cites this paper
• Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.

  2007cites this paper
• Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors

  2006cites this paper
• Use of neuraminidase inhibitors to combat pandemic influenza.

  2006cites this paper
• Avian influenza H5N1: is it a cause for concern?

  2006cites this paper
• Respiratory viral threats

  2006cites this paper
• Antiviral management of seasonal and pandemic influenza.

  2006cites this paper
• Antivirals for influenza: historical perspectives and lessons learned.

  2006cites this paper
• Pandemics and preparations.

  2006cites this paper
• Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses

  2005cites this paper
• Resistance to anti-influenza agents

  2005cites this paper
• Influenza Virus Susceptibility and Resistance to Oseltamivir

  2005cites this paper
• Influenza and the implications of a pandemic for Malta

  2005cites this paper
• Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.

  2003cites this paper